PXD065164 is an
original dataset announced via ProteomeXchange.
Dataset Summary
| Title | Intraductal xenografts reveal LOX inhibitor PXS-5505 as a translatable targeting strategy for lobular carcinoma exploiting a unique vulnerability |
| Description | Fifteen percent of breast cancers are invasive lobular carcinomas (ILCs), a specific histological subtype. Although ILCs have distinct clinicopathological features and pathognomonic CDH1 loss, no specific therapies exist because ILCs are underrepresented in clinical trials and preclinical models are lacking. We developed intraductal ILC xenograft models to test the hypothesis that the pan-LOX inhibitor (LOXi), PXS-5505, used in patients with myelofibrosis can be repurposed to target ILC-specific matrix dependency. LOXi blocks ILC progression in clinically relevant settings and alters collagen fiber organisation and cell matrix composition. In vitro screens identify ITGAV and ITGB5 loss as synthetic lethal in cells with CDH1 loss. Consistent with ILC specific dependency on ITG-mediated matrix interactions, expression of downstream factors CCN1, MYC, NFKB and AP-1 are increased in ILCs and downregulated by LOXi. We identify collagen fibre density and alignment, and MYC/AP-1 signatures as translatable endpoints of LOXi activity enabling needed clinical trials on ILCs. |
| HostingRepository | PRIDE |
| AnnounceDate | 2026-01-29 |
| AnnouncementXML | Submission_2026-01-29_12:32:39.645.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Graeme Benstead-Hume |
| SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: NEWT:9606; |
| ModificationList | No PTMs are included in the dataset |
| Instrument | Orbitrap Ascend |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
| 0 | 2025-06-18 09:09:27 | ID requested | |
| ⏵ 1 | 2026-01-29 12:32:40 | announced | |
Publication List
| Dataset with its publication pending |
Keyword List
| submitter keyword: PXS-5505, lobular carcinoma,LOX inhibitor |
Contact List
| Jyoti Choudhary |
| contact affiliation | Functional Proteomics, ICR |
| contact email | jyoti.choudhary@icr.ac.uk |
| lab head | |
| Graeme Benstead-Hume |
| contact affiliation | ICR |
| contact email | ghume@icr.ac.uk |
| dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2026/01/PXD065164 |
| PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD065164
- Label: PRIDE project
- Name: Intraductal xenografts reveal LOX inhibitor PXS-5505 as a translatable targeting strategy for lobular carcinoma exploiting a unique vulnerability